← All trials
NCT02450383
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2015
- Primary completion
- Sep 30, 2016
- Completion date
- Sep 30, 2016
- First posted
- May 21, 2015
- Last posted
- Oct 18, 2017
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of IowaLead sponsor
- University of IowaOverall official - principal investigator
- University of IowaReponsible party - principal investigator
- BioHorizons, Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.